(VONE) Vanguard Russell 1000 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US92206C7305 • Large Blend
VONE: Large-Cap, Stocks, United States
The Vanguard Russell 1000 Index Fund ETF Shares (NASDAQ: VONE) is designed to deliver exposure to the performance of the Russell 1000® Index, a widely recognized benchmark for large-capitalization U.S. equities. By employing a strict indexing strategy, the fund seeks to replicate the returns of its target index, making it a straightforward tool for investors aiming to capture the growth of Americas largest companies.
The Russell 1000® Index itself is constructed to represent the top 1,000 publicly traded U.S. firms by market capitalization, effectively covering about 90% of the total U.S. equity market. This makes the fund a highly efficient way to gain exposure to the backbone of corporate America. The fund is structured as an ETF, which means it can be traded throughout the day on the NASDAQ exchange, offering investors flexibility and liquidity.
As a non-diversified fund, VONE can have significant exposure to its top holdings, which aligns with the concentration of the Russell 1000® Index. This approach ensures that the fund closely tracks the performance of its benchmark. The funds expense ratio is characteristically low, a hallmark of Vanguards cost-efficient investment products, making it an attractive option for cost-conscious investors seeking long-term exposure to large-cap equities.
With approximately $5.6 billion in assets under management, VONE is a substantial player in the ETF space. It is categorized under the Large Blend segment, reflecting its focus on large-cap stocks and its neutral style between growth and value. The funds structure ensures that it holds securities in proportions that closely mirror the Russell 1000® Index, minimizing tracking error and delivering a reliable representation of its benchmark.
For investors and fund managers, VONE offers a combination of transparency, liquidity, and low fees, making it a practical choice for those looking to build or supplement large-cap equity exposure within their portfolios. Its alignment with the Russell 1000® Index ensures that it provides broad diversification across the largest and most established U.S. companies, while its ETF structure allows for seamless trading and portfolio adjustments.
Additional Sources for VONE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VONE ETF Overview
Market Cap in USD | 5,679m |
Category | Large Blend |
TER | 0.08% |
IPO / Inception | 2010-09-20 |
VONE ETF Ratings
Growth 5y | 78.4% |
Fundamental | - |
Dividend | 52.8% |
Rel. Strength Industry | -1.78 |
Analysts | - |
Fair Price Momentum | 261.37 USD |
Fair Price DCF | - |
VONE Dividends
Dividend Yield 12m | 1.22% |
Yield on Cost 5y | 2.33% |
Annual Growth 5y | 4.69% |
Payout Consistency | 93.4% |
VONE Growth Ratios
Growth Correlation 3m | 37.8% |
Growth Correlation 12m | 95.7% |
Growth Correlation 5y | 81.3% |
CAGR 5y | 14.64% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | 1.14 |
Alpha | -0.27 |
Beta | 1.01 |
Volatility | 11.07% |
Current Volume | 52.1k |
Average Volume 20d | 81.3k |
As of February 22, 2025, the stock is trading at USD 272.95 with a total of 52,113 shares traded.
Over the past week, the price has changed by -1.84%, over one month by -0.80%, over three months by +1.14% and over the past year by +22.13%.
Yes. Based on ValueRay Analyses, Vanguard Russell 1000 (NASDAQ:VONE) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.43 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VONE as of February 2025 is 261.37. This means that VONE is currently overvalued and has a potential downside of -4.24%.
Vanguard Russell 1000 has no consensus analysts rating.
According to ValueRays Forecast Model, VONE Vanguard Russell 1000 will be worth about 313.6 in February 2026. The stock is currently trading at 272.95. This means that the stock has a potential upside of +14.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 313.6 | 14.9% |